A
Ahmedin Jemal
Researcher at American Cancer Society
Publications - 568
Citations - 492750
Ahmedin Jemal is an academic researcher from American Cancer Society. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 132, co-authored 500 publications receiving 380474 citations. Previous affiliations of Ahmedin Jemal include Centers for Disease Control and Prevention & Emory University.
Papers
More filters
Journal ArticleDOI
Trends and Predictors of Chemotherapy Use among Thyroid Cancer Patients in the National Cancer Database (2004-2013).
TL;DR: Overall, chemotherapy use among MTCs increased marginally following the FDA's approval of MKIs in 2011, although their use remains very low.
Journal ArticleDOI
Trends in the use of proton beam therapy among newly diagnosed cancer patients in the United States.
TL;DR: Proton Beam Therapy is a potentially superior radiotherapy technology for tumors with complex anatomy surrounded by sensitive tissues and for childhood cancers where sparing sparing is limited.
Proceedings ArticleDOI
Abstract LB-171: Global variation in prostate cancer incidence and mortality rates, 1980-2013
TL;DR: In the most recent 5 years of data examined, prostate cancer incidence and mortality rates are decreasing or stabilizing in most parts of the world.
Survival impact of postoperative therapy modalities according to margin status in non–small cell lung cancer patients in the United States
Matthew P. Smeltzer,Chun Chieh Lin,Feng-Ming Spring Kong,Ahmedin Jemal,Raymond U. Osarogiagbon +4 more
TL;DR: In this paper, the authors attempted to validate NCCN adjuvant therapy guidelines after incomplete (R1/R2) resection of non-small cell lung cancer (NSCLC) based on low-level evidence.